Literature DB >> 29476906

The IASLC Lung Cancer Staging Project: A Renewed Call to Participation.

Dorothy J Giroux1, Paul Van Schil2, Hisao Asamura3, Ramón Rami-Porta4, Kari Chansky1, John J Crowley1, Valerie W Rusch5, Kemp Kernstine6.   

Abstract

Over the past two decades, the International Association for the Study of Lung Cancer (IASLC) Staging Project has been a steady source of evidence-based recommendations for the TNM classification for lung cancer published by the Union for International Cancer Control and the American Joint Committee on Cancer. The Staging and Prognostic Factors Committee of the IASLC is now issuing a call for participation in the next phase of the project, which is designed to inform the ninth edition of the TNM classification for lung cancer. Following the case recruitment model for the eighth edition database, volunteer site participants are asked to submit data on patients whose lung cancer was diagnosed between January 1, 2011, and December 31, 2019, to the project by means of a secure, electronic data capture system provided by Cancer Research And Biostatistics in Seattle, Washington. Alternatively, participants may transfer existing data sets. The continued success of the IASLC Staging Project in achieving its objectives will depend on the extent of international participation, the degree to which cases are entered directly into the electronic data capture system, and how closely externally submitted cases conform to the data elements for the project.
Copyright © 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Lung cancer databases; Lung cancer staging; TNM classification

Mesh:

Year:  2018        PMID: 29476906     DOI: 10.1016/j.jtho.2018.02.012

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  11 in total

1.  Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Keiju Aokage; Tokiko Nakai; Shingo Sakashita; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

2.  Non-small cell lung cancer transgressing an adjacent fissure: does one T category fit all?

Authors:  Paul E Van Schil
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  The Difference and Significance of Parietal Pleura Invasion and Rib Invasion in Pathological T Classification With Non-Small Cell Lung Cancer.

Authors:  Lei-Lei Wu; Chong-Wu Li; Kun Li; Li-Hong Qiu; Shu-Quan Xu; Wei-Kang Lin; Guo-Wei Ma; Zhi-Xin Li; Dong Xie
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

4.  The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and Opportunities.

Authors:  Raymond U Osarogiagbon; Ramon Rami-Porta; Ming Sound Tsao; Luis M Montuenga; Katherine K Nishimura; Dorothy J Giroux; William Travis; Hisao Asamura; Valerie Rusch; David P Carbone; Fred R Hirsch
Journal:  J Thorac Oncol       Date:  2021-03-23       Impact factor: 20.121

5.  Evolution of the surgical treatment of lung cancer at a tertiary referral center in Brazil, 2011-2018.

Authors:  Mariana Schettini Soares; Laura Maria Coltro; Pedro Henrique Cunha Leite; Priscila Berenice Costa; Letícia Leone Lauricella; Paulo Manuel Pêgo-Fernandes; Ricardo Mingarini Terra
Journal:  J Bras Pneumol       Date:  2020-12-16       Impact factor: 2.624

6.  New TNM staging in lung cancer (8th edition) and future perspectives.

Authors:  José-María Matilla; M Zabaleta; E Martínez-Téllez; J Abal; A Rodríguez-Fuster; J Hernández-Hernández
Journal:  J Clin Transl Res       Date:  2020-09-02

7.  Part-solid tumours: at the border of 2 worlds.

Authors:  Paul E Van Schil; Lawek Berzenji
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18

8.  Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.

Authors:  Jia Li; Feng Liu; Haining Yu; Chenglong Zhao; Zhenxiang Li; Haiyong Wang
Journal:  PeerJ       Date:  2019-12-03       Impact factor: 2.984

9.  5-aza-2'-deoxycytidine (DAC) treatment induces the MAGE-A10 expression and improves the cytotoxicity of MAGE-A10-specific CTLs in lung cancer cells.

Authors:  Zhenhua Li; Peng Guo; Peiyuan Guo; Keqin Dong; Fei Liu; Yunyan Wu; Juan Li; Baoen Shan; Meixiang Sang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

10.  Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer.

Authors:  Yanping Su; Meirong Huo; Lin Hua; Yuan Zhang; Jiawen Yi; Shu Zhang; Jie Li; Yuhui Zhang
Journal:  Cancer Manag Res       Date:  2021-05-18       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.